Ann: Appendix 4C Cash Flow Report, page-9

started down the path of collating historical Related Party Transaction amounts and found these gems

2018 Annual Report - just when everyone was celebrating the $100m sales growth that was going to come from expansion into China via signing with Careline

Interesting:



soft Revenue and EBITDA targets only, no setting the bar of achieving NPAT !!

chaaa chiiiing


2016 Annual Report - selling private companies to FOD shareholders


Gross Profit, EBITDA, $2m Marketing Spend !!! - where's the focus upon producing Net Profit for Shareholders ?

And then remember later in 2016 (FY2017 year) the Board voted down the acquisition of another Matt Bailey private company as being overpriced and at a bad time for the FOD share price and the extra dilution effect it would create

I'm starting to see a bit of a pattern here .......

Can we get the 2016 Board back do you reckon ?